241 related articles for article (PubMed ID: 11907461)
1. The new melanoma staging system.
Kim CJ; Reintgen DS; Balch CM;
Cancer Control; 2002; 9(1):9-15. PubMed ID: 11907461
[TBL] [Abstract][Full Text] [Related]
2. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
[TBL] [Abstract][Full Text] [Related]
3. The revised American Joint Committee on Cancer staging system for melanoma.
Thompson JA
Semin Oncol; 2002 Aug; 29(4):361-9. PubMed ID: 12170439
[TBL] [Abstract][Full Text] [Related]
4. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
Rousseau DL; Ross MI; Johnson MM; Prieto VG; Lee JE; Mansfield PF; Gershenwald JE
Ann Surg Oncol; 2003 Jun; 10(5):569-74. PubMed ID: 12794025
[TBL] [Abstract][Full Text] [Related]
5. New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
Semin Surg Oncol; 2003; 21(1):43-52. PubMed ID: 12923915
[TBL] [Abstract][Full Text] [Related]
6. A new American Joint Committee on Cancer staging system for cutaneous melanoma.
Balch CM; Buzaid AC; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Houghton A; Kirkwood JM; Mihm MF; Morton DL; Reintgen D; Ross MI; Sober A; Soong SJ; Thompson JA; Thompson JF; Gershenwald JE; McMasters KM
Cancer; 2000 Mar; 88(6):1484-91. PubMed ID: 10717634
[TBL] [Abstract][Full Text] [Related]
7. Melanoma staging and sentinel lymph node biopsy.
Forsea AM
Acta Dermatovenerol Croat; 2010; 18(4):279-88. PubMed ID: 21251448
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
9. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
10. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.
Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
J Clin Oncol; 2001 Aug; 19(16):3635-48. PubMed ID: 11504745
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
12. A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model.
Callender GG; Gershenwald JE; Egger ME; Scoggins CR; Martin RC; Schacherer CW; Edwards MJ; Urist MM; Ross MI; Stromberg AJ; McMasters KM
J Am Coll Surg; 2012 Apr; 214(4):608-17; discussion 617-9. PubMed ID: 22342785
[TBL] [Abstract][Full Text] [Related]
13. The new staging system for cutaneous melanoma in the era of lymphatic mapping.
Rousseau DL; Gershenwald JE
Semin Oncol; 2004 Jun; 31(3):415-25. PubMed ID: 15190500
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
15. An evidence-based staging system for cutaneous melanoma.
Balch CM; Soong SJ; Atkins MB; Buzaid AC; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
CA Cancer J Clin; 2004; 54(3):131-49; quiz 182-4. PubMed ID: 15195788
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
Nahabedian MY; Tufaro AP; Manson PN
Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
Balch CM; Soong SJ; Gershenwald JE; Thompson JF; Reintgen DS; Cascinelli N; Urist M; McMasters KM; Ross MI; Kirkwood JM; Atkins MB; Thompson JA; Coit DG; Byrd D; Desmond R; Zhang Y; Liu PY; Lyman GH; Morabito A
J Clin Oncol; 2001 Aug; 19(16):3622-34. PubMed ID: 11504744
[TBL] [Abstract][Full Text] [Related]
18. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma.
Starz H; Balda BR; Krämer KU; Büchels H; Wang H
Cancer; 2001 Jun; 91(11):2110-21. PubMed ID: 11391592
[TBL] [Abstract][Full Text] [Related]
19. Sentinel node biopsy status is strongly predictive of survival in cutaneous melanoma: Extended follow-up of Oxford patients from 1998 to 2014.
Thomson DR; Rughani MG; Kuo R; Cassell OCS
J Plast Reconstr Aesthet Surg; 2017 Oct; 70(10):1397-1403. PubMed ID: 28625757
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.
Ellis MC; Weerasinghe R; Corless CL; Vetto JT
Am J Surg; 2010 May; 199(5):663-8. PubMed ID: 20466113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
